Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Clinical trial NCT02201303 · COMPLETED

Trial details

NCT number: NCT02201303
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Respiratory Syncytial Virus

Start date: 2014-01-13
Primary completion: 2015-07-02
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.